In our study, we also observed greater levels of MMP-2 in patients with other lung neoplasms than in patients with adenocarcinoma or squamous cell carcinoma that could be attributed to a higher prevalence of distant metastases in this group of patients, which included individuals with metastases to the lungs from other neoplasms. This evidence concerns the gene MMP2 and Neoplasm of the lung.